Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vishal J Patel

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
International Journal of Toxicology|August 30, 2025
A 1-Month Exploratory Combination Safety and Toxicity Study of Co-Administration of Sitagliptin and Telmisartan in Male Wistar Han RatsChitrang R Shah, Sandip B Patel, Vishal J Patel, et al.
Drug Research|July 11, 2024
HIF Stabilizer Desidustat Protects against Complement-Mediated DiseasesVishal J Patel, Amit A Joharapurkar, Samadhan G Kshirsagar, et al.
Journal of Diabetes|October 21, 2014
Pharmacological characterization of ZYDPLA1, a novel long-acting dipeptidyl peptidase-4 inhibitorMukul R Jain, Amit A Joharapurkar, Rajesh H Bahekar, et al.
Drug Research|February 4, 2017
Is the Inhibition of Dipeptidyl Peptidase-4 (DDP-4) Enzyme Route Dependent and/or Driven by High Peak Concentration?- Seeking Answers with ZYDPLA1, a Novel Long Acting DPP-4 Inhibitor, in a Rodent ModelHarilal Patel, Amit A Joharapurkar, Rajesh Bahekar, et al.
International Journal of Toxicology|February 27, 2026
Pair-Feeding Differentiates Feed-Dependent and Pharmacodynamic Effects of Telmisartan in Wistar RatsChitrang R Shah, Sandip B Patel, Vishal J Patel, et al.
Experimental Neurology|February 6, 2025
Prolyl hydroxylase inhibitor desidustat improves stroke outcomes via enhancing efferocytosis in mice with chronic kidney diseaseHarpreet Kaur, Nilesh Pandey, Lakshmi Chandaluri, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
International Journal of Toxicology|August 30, 2025
A 1-Month Exploratory Combination Safety and Toxicity Study of Co-Administration of Sitagliptin and Telmisartan in Male Wistar Han RatsChitrang R Shah, Sandip B Patel, Vishal J Patel, et al.
Drug Research|July 11, 2024
HIF Stabilizer Desidustat Protects against Complement-Mediated DiseasesVishal J Patel, Amit A Joharapurkar, Samadhan G Kshirsagar, et al.
Journal of Diabetes|October 21, 2014
Pharmacological characterization of ZYDPLA1, a novel long-acting dipeptidyl peptidase-4 inhibitorMukul R Jain, Amit A Joharapurkar, Rajesh H Bahekar, et al.
Drug Research|February 4, 2017
Is the Inhibition of Dipeptidyl Peptidase-4 (DDP-4) Enzyme Route Dependent and/or Driven by High Peak Concentration?- Seeking Answers with ZYDPLA1, a Novel Long Acting DPP-4 Inhibitor, in a Rodent ModelHarilal Patel, Amit A Joharapurkar, Rajesh Bahekar, et al.
International Journal of Toxicology|February 27, 2026
Pair-Feeding Differentiates Feed-Dependent and Pharmacodynamic Effects of Telmisartan in Wistar RatsChitrang R Shah, Sandip B Patel, Vishal J Patel, et al.
Experimental Neurology|February 6, 2025
Prolyl hydroxylase inhibitor desidustat improves stroke outcomes via enhancing efferocytosis in mice with chronic kidney diseaseHarpreet Kaur, Nilesh Pandey, Lakshmi Chandaluri, et al.
Pageof 3